Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-04-29

Clinical Trial Update: Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

View source ↗

Summary

An ongoing long-term observational study is evaluating disease-free survival and overall survival for the adjuvant FOLFIRINOX regimen in pancreatic cancer patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOLFIRINOX regimen (5-fluorouracil, leucovorin, oxaliplatin, irinotecan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Adjuvant Chemotherapy | Status: RECRUITING